Vitamin B 12 deficiency is an urgent public health problem that disproportionately affects individuals in low-and middle-income settings, where the burden of neglected tropical diseases (NTDs) is also unacceptably high. Emerging evidence supports a potential role of micronutrients in modulating the risk and severity of NTDs. However, the role of vitamin B 12 in NTD pathogenesis is unknown. This systematic review was conducted to evaluate the evidence on the role of vitamin B 12 in the etiology of NTDs. Ten studies were included in this review: one study using an in vitro/animal model, eight observational human studies and one ancillary analysis conducted within an intervention trial. Most research to date has focused on vitamin B 12 status and helminthic infections. One study examined the effects of vitamin B 12 interventions in NTDs in animal and in vitro models. Few prospective studies have been conducted to date to examine the role of vitamin B 12 in NTDs. The limited literature in this area constrains our ability to make specific recommendations. Larger prospective human studies are needed to elucidate the role of vitamin B 12 in NTD risk and severity in order to inform interventions in at-risk populations.
Introduction Neglected tropical diseases (NTDs)
NTDs are a group of 17 infectious diseases that affect more than 2.7 billion people globally and are endemic in more than 149 countries. 1, 2 Neglected tropical diseases (NTDs) include viral, bacterial, protozoan and helminthic infections. Chronic infections from NTDs can result in extensive morbidity and disability; 3 reduced quality of life, work productivity, education attainment and social well-being [4] [5] [6] and may increase the severity and risk of death from coinfections. 5 NTDs disproportionately affect the world's poorest populations in endemic tropical countries. In Africa, NTDs account for approximately 73% of the total burden of disease and 71% of deaths on the continent. 7 In Latin America and the Caribbean, 8.8% of the population is affected by at least one NTD. 5 Women and young children are at the highest risk of infection due to greater exposure, poor sanitation and barriers to accessing treatment.
Nutrition and immunity
The vicious cycle of malnutrition and infection was first noted more than 50 years ago, with malnutrition as both a risk factor and consequence of infection. Hookworm infection and schistosomiasis are well-established culprits in iron-deficiency anemia due to gastrointestinal blood loss and micronutrient supplements are frequently given in combination with deworming treatment. 8, 9 Micronutrient deficiencies, including vitamins and minerals, influence host innate and adaptive immune responses to infections, including macrophage, lymphocyte and metabolic functions 10, 11 and the risk and severity of infectious diseases. 12 Vitamins such as A, D, E, folate and vitamin B 12 confer protection against oxidative stress, enhance immune cell proliferation and differentiation, regulate epithelial integrity and improve antigen presentation. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] For example, vitamin A deficiency impairs both humoral and cellmediated immunity and increased susceptibility to infectious diseases. 12 Minerals such as zinc, iron and copper are also critical for the host immune system. [20] [21] [22] [23] [24] [25] For example, zinc is involved in the regulation of innate and adaptive immune responses and influences lymphocyte maturation, cytokine production and the generation of free radicals while maintaining normal macrophage and natural killer cell activity. 26 Emerging evidence supports a role of micronutrient deficiencies in the risk and severity of NTDs, 27 although the effects of micronutrient supplementation in NTDs have not been established.
Vitamin B 12
Vitamin B 12 deficiency (<148.0 pmol/L) is a major public health problem worldwide. 28 Inadequate vitamin B 12 status leads to reduced DNA synthesis, genomic hypomethylation and chromosomal aberrations. 29 In addition, vitamin B 12 deficiency during pregnancy and early childhood has been associated with an increased risk of adverse pregnancy outcomes 30 and impaired psychomotor and cognitive development. 31, 32 The classic cause of vitamin B 12 deficiency is pernicious anemia, an autoimmune disease that destroys parietal cells, which are required for intrinsic factor (IF)-mediated vitamin B 12 absorption. 33 In settings where consumption of animal products is inadequate or intestinal infections are common, the prevalence of vitamin B 12 deficiency is high. 34 The prevalence of vitamin B 12 deficiency have been reported to be as high as 40% in Latin America, 35 70% in Africa 36 and 70 to 80% in South Asia. 37, 38 Regions with a high prevalence of vitamin B 12 deficiency are also the regions with the greatest NTD burden.
In the absence of sufficient vitamin B 12 , impaired DNA synthesis can lead to bone marrow aplasia and consequent cytopenia, including lymphopenia. 39, 40 Although there are limited data on vitamin B 12 and immunity, some studies have demonstrated associations between vitamin B 12 status and leukocyte cell counts. Studies from Japan reported lower CD8 T-cell counts among patients with pernicious anemia compared with healthy controls and that patients with vitamin B 12 deficient anemia had improvements in CD8 T-cell and natural killer cell counts after administration of methyl-cobalamin injections. 19, 41 In another cohort study from Turkey, patients with pernicious anemia given daily intramuscular vitamin B 12 injections had significantly increased total leukocyte counts, CD8 T-cell counts, natural killer cell activity and immunoglobulins. 42 The restoration of immune cells by vitamin B 12 interventions may be due to the role of vitamin B 12 in DNA synthesis, although the mechanisms have not been identified.
Despite these immune cell associations, specific mechanisms of vitamin B 12 in the host immune response to infection by NTDs have not been elucidated. Given the role of vitamin B 12 in immune cell cytogenesis, host vitamin B 12 status may impact the risk, severity and clinical presentation of NTDs.
The high coprevalence of vitamin B 12 deficiency and NTDs in low-and middle-income settings and the increasing evidence that micronutrients may play a role in influencing the risk and severity of NTDs have stimulated interest in vitamin B 12 research. Further, vitamin B 12 supplementation represents a potential adjunct for NTD prevention and treatment. However, there is a lack of data on the efficacy of vitamin B 12 interventions in alleviating the risk and severity of NTDs. No reviews to date have been conducted to examine the role of vitamin B 12 in NTDs. A review is warranted to summarize existing data on vitamin B 12 and NTDs to inform screening and targeted interventions for prevention and treatment.
The objective of this review was to examine the evidence on the role of vitamin B 12 in NTDs. Specifically, we hypothesize that vitamin B 12 deficiency increases the risk and severity of NTD infection and that existing NTD infections can lead to vitamin B 12 deficiency. We examine evidence from animal and in vitro studies, observational studies and intervention trials. We then discuss research gaps and implications for the development of interventions and public health approaches to reduce the risk and severity of NTDs, with emphasis on low-and middle-income settings.
Methods

Search strategy and selection process
We conducted a structured literature search using the MEDLINE electronic database. Relevant Medical Subject Heading (MeSH) terms were used to identify published studies through 27 September 2015. The search strategy and MeSH terms used are provided in Table 1 and the findings are summarized in Figure 1 .
The initial inclusion criteria for abstracts in this review were the inclusion of data on vitamin B 12 status or intake and inclusion of data on at least one of the 17 NTDs identified by the World Health Organization. 43 The following biomarkers of vitamin B 12 status were included: serum and plasma vitamin B 12 The available abstracts of all studies were searched, full-text articles were extracted and reviewed and the following inclusion criteria were applied: availability of data on vitamin B 12 intake or status and at least one of 17 NTDs, and reported association between vitamin B 12 and an NTD-related outcome. In vitro studies, animal studies, observational cross-sectional studies, casecontrol studies, cohort studies, randomized trials, interventions, quasi-randomized trials and uncontrolled trials were included. Sources were retrieved, collated, indexed and assessed for A. J. Layden et al.
vitamin B 12 and NTD outcome data. An additional search was conducted to find review articles, which were examined to cross-reference other relevant studies. Standardized data tables were created and used to extract and summarize key information from observational and experimental studies. As part of this protocol, publication date, author names, study design, setting, target population, methods, definitions of exposures and outcomes, main findings and study limitations were recorded. For each individual outcome we assessed the quality of the evidence, risk of bias, heterogeneity, precision of effect estimates and potential and residual confounding.
Results
The structured literature search yielded 516 articles that were reviewed for potential inclusion in this review. After 479 articles were excluded (missing abstracts, n=263; reviews or metaanalyses, n=31; case reports, n=27; missing data on NTDs, n=85; missing data on vitamin B 12 , n=20; laboratory methods, n=1; missing data on vitamin B12, NTDs, or the association between vitamin B 12 and NTDs, n=157), 37 full-text articles were extracted for further review. After excluding 27 articles that did not meet the aforementioned inclusion criteria (nonEnglish language, n=1; laboratory methods, n=1; missing data on vitamin B 12 , n=3; missing data on NTDs, n=9; no data on the associations between vitamin B 12 and NTDs, n=13), 10 studies were included in this review. These included one in vitro/animal study, eight observational human studies (six cross-sectional, one case-control and one cohort study) and one ancillary analysis conducted within an intervention trial. NTDs that were examined in association with vitamin B 12 Figure 1 and findings from these studies are summarized in detail in Tables 2-4 .
Helminths
Helminths are intestinal parasitic worms, whipworms and hookworms. Helminthic infections affect more than 1 billion people worldwide (7.8% of the global population is infected with hookworms, 14.5% with Ascaris lumbricoides and 8.3% with Trichuris trichiura). 54 Pregnant women, children and elderly populations are at higher risk of helminthic infections. 55 Helminthic infections have been associated with malnutrition due to micronutrient malabsorption, blood loss and inflammation. 3, [55] [56] [57] Six observational studies identified in this review examined the role of vitamin B 12 in helminth infections in humans. Study populations were based in regions with high helminth infection rates: South Asia (Thailand, India and Bangladesh), Latin America (Panama and Cuba) and Oceania (Papua New Guinea). 
Transactions of the Royal Society of Tropical Medicine and Hygiene
Continued
Transactions of the Royal Society of Tropical Medicine and Hygiene Similarly a case-control study in Cuba investigating the nutritional consequences of T. trichiura infection in at-risk children reported that vitamin B 12 concentrations did not significantly differ between patients with T. trichiura infection and uninfected patients (232.6 vs 261.0 pmol/L; p>0.05). 45 A cross-sectional study of school-age children from India was conducted to assess the burden of vitamin deficiencies; no statistically significant differences in mean vitamin B 12 concentrations between individuals with any type of helminth (A. lumbricoides, hookworm, T. trichiura, T. saginata; p>0.05) infection and uninfected individuals were found. 47 A cohort study of children (1-5 y) from Panama was conducted to identify predictors of serum vitamin B 12 concentrations and vitamin B 12 intake, including A. lumbricoides infection. 48 Although an increased frequency of diarrheal episodes was associated with lower vitamin B 12 concentrations, A. lumbricoides infection intensity (eggs/g stool) was not significantly associated with serum vitamin B 12 levels.
Two observational analyses reported the prevalence of impaired vitamin B 12 status and absorption among individuals with helminthic infections. A cross-sectional analysis was conducted at baseline prior to intervention in the Maternal and Infant Nutrition Interventions in Matlab (MINIMat) randomized trial among pregnant women in rural Bangladesh. At baseline, Ascaris infection (i.e., stool samples positive for Ascaris parasites) was associated with vitamin B 12 deficiency (<150.0 pmol/L; p<0.05). Furthermore, in women, A. lumbricoides infection was associated with significantly higher odds of vitamin B 12 deficiency (<150.0 pmol/L) compared with women without Ascaris infection (odds ratio [OR] 1.49 [95% confidence interval {CI} 1.06 to 2.09], p<0.05) after adjusting for socioeconomic status and food security. 46 In a cross-sectional study of patients with F. buski in Thailand, the effect of F. buski infection on intestinal absorption disorders was assessed. Although no specific associations were determined, 80% (n=8/10) of patients infected with F. buski had vitamin B 12 absorption levels below the reference range of absorption (≥50%) as determined by a modified Schilling test. 49 Six of the nine participants had low serum vitamin B 12 concentrations (<200.0 pg/mL). One patient had histologic evidence of damaged jejunal villi, suggesting intestinal damage as a potential mechanism for impaired vitamin B 12 absorption in F. buski infection. 49 An intervention was conducted in Spain to examine the effects of different anthelminthic treatments on clinical outcomes in 86 children with Giardia lamblia, Cryptosporidium parvum or E. vermicularis. In ancillary analyses of data, investigators examined changes in plasma vitamin B 12 concentrations before and after treatment. 52 The mean serum vitamin B 12 concentrations significantly increased after 3 months of antiparasitic treatment (630.57 ±200.97 vs 667.97±181.55 pg/mL; p=0.002). 52 
Other NTDs
Three studies reported associations between vitamin B 12 and other NTDs, including Chagas disease (n=1) and leprosy (n=2). Chagas disease is caused by the protozoan Trypanosoma cruzi. Currently 18 million individuals in Latin America alone suffer from Chagas disease. 58 Leprosy is caused by the bacterium Mycobacterium leprae, with approximately 250 000 new cases each year. 59 In an animal study from Buenos Aires, five groups of mice (five mice per group) were infected with T. cruzi and the number of parasites found in circulation (parasites/mL blood) was measured every 2 d after infection. 53 Mice were randomized to the following treatment groups: vitamin B 12 ; vitamin B 12 and ascorbic acid; benznidazole (Bnz); vitamin B 12 , ascorbic acid and Bnz; and control (0.1 M phosphate buffer solution). Treatments were administered daily by intraperitoneal injection from days 5 to 9 and days 12 to 16 after infection. At the peak of parasitemia for the control group (i.e., day 13), the concentrations of circulating parasites were significantly lower in all intervention groups compared with controls (group 1: 2.23±0.28×10 6 parasites/mL, group 2: 1.26±0.17×10 6 parasites/mL, group 3: 1.43±0.12×10 6 parasites/mL and group 4: 1.33±0.25×10 6 parasites/mL vs the control group: 4.18±0.02×10 6 parasites/mL; p<0.01 for each group vs control group). Additionally, the group receiving vitamin B 12 , ascorbic acid and Bnz (group 4) had a significantly higher survival rate after 100 d compared with the control group (83.3% vs 0%; p<0.05). 53 No other significant differences were noted for the vitamin B 12 -only group compared with the control group.
In the same study, 53 in vitro experiments using T. cruzi epimastigotes from 3-d cultures, bloodstream T. cruzi trypomastigotes and T. cruzi amastigotes cultured in a Roswell Park Memorial Institute medium without a phenol red murine macrophage cell line were treated with different doses of cyanocobalamin to determine the effects of vitamin B 12 on parasite growth inhibition compared with Bnz treatment. Growth inhibition was measured as the change in cell density (cell count or light absorbance) from pretreatment to posttreatment. With increasing vitamin B 12 concentrations, the T. cruzi epimastigote growth rate decreased. The half maximal inhibitory concentration (IC50) values for trypomastigotes and epimastigotes were 2.6-to 4-fold higher (9.46±1.2 vs 30.26±2.85) and 1.7-to 3.6-fold higher (2.42±0.54 vs 5.86±0.93) for vitamin B 12 compared with Bnz.
In a cross-sectional study in India, Karat and Rao 50 characterized the hematological status of leprosy patients (n=904), categorized into four groups based on clinical presentation: lepromatous, tuberculoid, borderline and indeterminate. The mean serum vitamin B 12 concentrations were significantly higher in leprosy patients in the lepromatous group compared with patients in the other clinical groups (i.e., tuberculoid, borderline and indeterminate groups) (p<0.05). In men, serum vitamin B 12 concentrations were lower in patients in the lepromatous group In the following year, additional analyses of the previous cross-sectional population-based survey were conducted among individuals with lepromatous leprosy (n=321). 51 Investigators examined the associations between the bacterial load (i.e., bacterial index) and serum vitamin B 12 concentrations (pg/100 mL). A higher leprosy bacterial load was significantly associated with higher serum vitamin B 12 concentrations (p<0.05). Mean serum vitamin B 12 concentrations were also higher among patients with late disease (>1 y) compared with early disease (<1 y; 226.8 pg/100 mL [SE 22.4] 
Discussion
There is limited evidence to date on the relationship between vitamin B 12 status and NTD infection. In this review, 8 of the 10 included studies provided support for a potential role of vitamin B 12 in the occurrence or severity of NTD infections, including helminths, T. cruzi and leprosy. Two human population studies demonstrated that individuals with an NTD infection had lower vitamin B 12 status or impaired vitamin B 12 absorption compared with uninfected individuals, and two studies demonstrated that serum vitamin B 12 concentrations increased after infection treatment. In contrast, one observational study noted higher vitamin B 12 concentrations in individuals with an NTD infection. Overall, there is limited evidence of the effects of vitamin B 12 on NTD pathogenesis. Only one experimental study has been conducted to date, using animal and cell models, to examine the effects of vitamin B 12 supplementation on NTD severity and no randomized trials have been conducted in at-risk human populations.
Research on vitamin B 12 and NTDs to date has primarily focused on helminthic infections. Cross-sectional and observational cohort studies have demonstrated that helminthic infections are associated with lower vitamin B 12 concentrations, even after adjusting for potential confounders, including socioeconomic status and food security, 46 and intestinal damage due to helminthic infection impaired vitamin B 12 absorption. 49 Lower circulating vitamin B 12 concentrations may be associated with helminth infections due to malabsorption. Evidence from a breadth of studies has established the link between helminth infections and micronutrient deficiencies resulting from malabsorption due to intestinal obstruction and damage to the mucosal lining, which likely compromises absorption of vitamin B 12 . 60, 61 Vitamin B 12 can only be absorbed in the ileum when bound to intrinsic factor. 62 Malabsorption of vitamin B 12 may occur if there is destruction of the receptor of intrinsic factor-bound vitamin B 12 , cubulin, such as in chronic intestinal infections, or impaired production of intrinsic factor that occurs with disrupted intestinal pH. Lower gastric pH due to Helicobacter pylori infection causes atrophy of the gastric glands, which also produce intrinsic factor necessary for vitamin B 12 absorption. 63 Helminthic infections may also decrease the absorption of vitamin B 12 due to hyporexia and increased gastric motility from diarrhea, two common symptoms of intestinal helminthes. 60, 61 Vitamin B 12 deficiency may predispose an individual to helminth infections by disrupting gastrointestinal epithelial growth. Given the role of vitamin B 12 in DNA synthesis and methylation, 64 insufficient vitamin B 12 status may diminish the host's ability to regenerate gastrointestinal epithelial cells, which require high rates of turnover in the body. 65 Gut epithelial cells play a critical role in protection against pathogens (e.g., helminths), providing a barrier to entry as part of the host innate immunity, and through production of mucous and immunoglobulin A. 66 Additionally, gastrointestinal epithelial tuft cells promote a type 2 T helper cell immune response to pathogens, such as helminths. 67 Other mechanisms may explain the potential links between vitamin B 12 and NTDs, though direct evidence is limited. Parasites utilize the host's energy and micronutrients for survival and reproduction. For example, Plasmodium falciparum, the malaria-causing protozoan, utilizes host folate and is often associated with a high prevalence of folate deficiencies in malaria-endemic areas. 68, 69 The potential requirements of NTD agents for vitamin B 12 are not known.
Vitamin B 12 status may increase the likelihood of an NTD infection by affecting host immunity and cell susceptibility to oxidative damage and inflammation. In one-carbon metabolism, vitamin B 12 is required as a cofactor for methionine synthase to remethylate homocysteine to methionine. Insufficient vitamin B 12 results in elevated homocysteine concentrations, 30, 70 which have been associated with oxidative stress and increased release of inflammatory cytokines. 71 Moreover, the one-carbon cycle is essential for nucleotide synthesis and DNA formation; both processes are critical when high rates of cell synthesis are needed, such as in childhood development and in response to infection. 70 As such, inadequate vitamin B 12 status may impair rapid immune cell proliferation of monocytes, natural killer cells or B and T cells normally required for innate and adaptive immune response to infection.
Research gaps and future directions
This review has several limitations that constrain the interpretation of findings, including the limited number and design of the studies, small number of participants, lack of intervention studies and appropriate control groups and overall low quality of evidence. Several of the research studies were conducted among high-risk populations, including incarcerated individuals, 44 pregnant women 46 and young children, 45, 47, 48 which may be subject to selection bias and limits the generalizability of findings.
To date, most studies on NTDs and vitamin B 12 have been observational in nature and were limited by inadequate adjustment for potential confounders, including concurrent infections, socioeconomic status and general malnutrition. In resourcelimited settings, vitamin B 12 deficiency is often concomitant with inadequate consumption of animal-source foods, protein intake and other micronutrient deficiencies, such as folate and iron. 72 These nutritional deficiencies are also associated with impaired immune response, cell growth and epithelial integrity and an increased risk or severity of NTD infections. Several poverty-related factors are potential confounders of the association between vitamin B 12 deficiency and increased risk of NTDs. For example, lower income or socioeconomic status may be associated with both malnutrition (e.g., inadequate vitamin B 12 intake or bioavailability) and poorer sanitation and living conditions (i.e., toilets, potable water, fecal contamination, open defecation), which are associated with increased exposure to NTDs. Although some of the observational studies included in this review adjusted for potential confounders in multivariate analyses, residual confounding of the associations between vitamin B 12 and NTDs by these covariates may lead to biased results and constrain the interpretation of findings.
Few rigorous prospective observational studies or randomized clinical trials have been conducted to date in which the primary objective was to examine the role of vitamin B 12 in the etiology of NTDs. Most of the studies included in this review were cross-sectional in design and assessed the prevalence of vitamin B 12 status and NTD infection at a single time point. This constrains the ability to establish temporal associations between vitamin B 12 and NTD infections and infer causality. The limited temporal assessment also constrains our ability to examine changes in vitamin B 12 status during the course of infection to determine if or when nutritional supplementation may be beneficial.
No randomized clinical trials have been conducted to date to determine the effects of vitamin B 12 on the risk and severity of NTDs. Only one study has been conducted to examine the effects of vitamin B 12 interventions in Chagas disease, but this study was conducted in animal and cell models. This study included vitamin B 12 in combination with Bnz and/or other micronutrients, and similar effects were not observed with vitamin B 12 supplementation alone. Further experimental studies in cell and animal models are required to determine the effects of vitamin B 12 on NTD risk and morbidity. In particular, future studies should include more detailed biochemical analysis, including measurement of inflammatory markers, to evaluate the effect of vitamin B 12 on host inflammation in the context of infection.
The studies included in this review all assessed total serum or plasma vitamin B 12 30, [73] [74] [75] [76] Additionally, although research to date suggests that helminthic infections impair vitamin B 12 absorption, measurements of small intestine epithelial integrity and circulating and functional vitamin B 12 biomarkers at multiple time points are needed to elucidate the directions of associations, how these temporal associations vary over time and potential mechanisms.
Conclusions
The lack of sufficient literature on the role of vitamin B 12 in NTDs provides limited evidence to inform specific recommendations. Although findings from some experimental animal and observational human studies suggest that there may be a potential benefit for vitamin B 12 on the risk and severity of some NTDs, the limited number and design of studies, lack of intervention studies and overall low quality of evidence constrain the interpretation of findings. Future prospective studies are needed to establish the role of vitamin B 12 in the etiology of NTDs and potential clinical significance, including how vitamin B 12 status and NTD-related morbidities change over the course of infection. Laboratory studies in animal and cell models are needed to elucidate the underlying mechanisms linking vitamin B 12 status and NTD infections. Further research is needed to inform the development of appropriate interventions for NTD prevention and control.
